Ventures West 8 Limited Partnership - Net Worth and Insider Trading
Ventures West 8 Limited Partnership Net Worth
The estimated net worth of Ventures West 8 Limited Partnership is at least $66,097 dollars as of 2024-09-20. Ventures West 8 Limited Partnership is the 10% Owner of Neoleukin Therapeutics Inc and owns about 18,939 shares of Neoleukin Therapeutics Inc (NLTX) stock worth over $66,097. Details can be seen in Ventures West 8 Limited Partnership's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ventures West 8 Limited Partnership has not made any transactions after 2014-03-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ventures West 8 Limited Partnership
Ventures West 8 Limited Partnership Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ventures West 8 Limited Partnership owns 2 companies in total, including Alder BioPharmaceuticals Inc (ALDR) , and Neoleukin Therapeutics Inc (NLTX) .
Insider Ownership Summary of Ventures West 8 Limited Partnership
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALDR | Alder BioPharmaceuticals Inc | 2014-05-13 | 10 percent owner |
| NLTX | Neoleukin Therapeutics Inc | 2014-03-06 | 10 percent owner |
Ventures West 8 Limited Partnership Latest Holdings Summary
Ventures West 8 Limited Partnership currently owns a total of 1 stock. Ventures West 8 Limited Partnership owns 18,939 shares of Neoleukin Therapeutics Inc (NLTX) as of March 6, 2014, with a value of $66,097.
Latest Holdings of Ventures West 8 Limited Partnership
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NLTX | Neoleukin Therapeutics Inc | 2014-03-06 | 18,939 | 3.49 | 66,097 |
Holding Weightings of Ventures West 8 Limited Partnership
Ventures West 8 Limited Partnership Form 4 Trading Tracker
According to the SEC Form 4 filings, Ventures West 8 Limited Partnership has made a total of 0 transactions in Neoleukin Therapeutics Inc (NLTX) over the past 5 years. The most-recent trade in Neoleukin Therapeutics Inc is the sale of 0 shares on March 6, 2014, which brought Ventures West 8 Limited Partnership around $0.
Insider Trading History of Ventures West 8 Limited Partnership
- 1
Ventures West 8 Limited Partnership Trading Performance
Ventures West 8 Limited Partnership Ownership Network
Ventures West 8 Limited Partnership Owned Company Details
What does Alder BioPharmaceuticals Inc do?
Who are the key executives at Alder BioPharmaceuticals Inc?
Ventures West 8 Limited Partnership is the 10 percent owner of Alder BioPharmaceuticals Inc. Other key executives at Alder BioPharmaceuticals Inc include 10 percent owner H Lundbeck A S , Chief Medical Officer Paul Streck , and director & President and CEO Robert Azelby .
Alder BioPharmaceuticals Inc (ALDR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alder BioPharmaceuticals Inc (ALDR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alder BioPharmaceuticals Inc (ALDR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alder BioPharmaceuticals Inc (ALDR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alder BioPharmaceuticals Inc Insider Transactions
Ventures West 8 Limited Partnership Mailing Address
Above is the net worth, insider trading, and ownership report for Ventures West 8 Limited Partnership. You might contact Ventures West 8 Limited Partnership via mailing address: C/o Five Corners Capital, 700 West Georgia Street, Suite 2500, Vancouver A1 V7y 1b3.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
